| 26th Apr 2024 7:00 am |
RNS |
Annual Report & Financial Statements - 31 Dec 2023 |
| 5th Apr 2024 7:00 am |
RNS |
Response to Share Price Movement |
| 11th Mar 2024 7:00 am |
RNS |
Positive Results: Midkine mRNA and STAT-6 siRNA |
| 6th Feb 2024 7:00 am |
RNS |
Operations Update |
| 24th Nov 2023 7:00 am |
RNS |
Change of Auditor |
| 6th Nov 2023 7:00 am |
RNS |
Significant Mesodermal Killer Cell Milestone |
| 27th Sep 2023 7:00 am |
RNS |
Interim Results to 30 June 2023 |
| 22nd Sep 2023 11:42 am |
RNS |
Investor Presentation via Investor Meet Company |
| 14th Aug 2023 7:00 am |
RNS |
Expansion of Patent Portfolio |
| 7th Aug 2023 7:00 am |
RNS |
Development of New Novel siRNA Therapeutics |
| 2nd Aug 2023 7:00 am |
RNS |
Director/PDMR Shareholding |
| 12th Jul 2023 10:27 am |
RNS |
Director/PDMR Shareholding |
| 29th Jun 2023 10:05 am |
RNS |
Results of AGM |
| 29th Jun 2023 7:00 am |
RNS |
AGM Statement |
| 27th Jun 2023 7:00 am |
RNS |
Investor Presentation via Investor Meet Company |
| 26th Jun 2023 2:41 pm |
RNS |
Director/PDMR Shareholding |
| 26th Jun 2023 10:36 am |
RNS |
Director/PDMR Shareholding |
| 26th Jun 2023 10:00 am |
RNS |
Director/PDMR Shareholding |
| 22nd Jun 2023 7:00 am |
RNS |
RNA Medicine Shows In Vitro Anti-Cancer Efficacy |
| 19th Jun 2023 7:00 am |
RNS |
Antibody Program Results & Orphan Drug Indication |
| 13th Jun 2023 7:00 am |
RNS |
Anti-Cancer MDK mRNA - Positive in vitro Results |
| 7th Jun 2023 10:11 am |
RNS |
Restoration of Trading |
| 6th Jun 2023 7:00 am |
RNS |
Notice of Annual General Meeting |
| 5th Jun 2023 7:00 am |
RNS |
Annual Report & Financial Statements - 31 Dec 2022 |
| 2nd May 2023 7:56 am |
RNS |
Suspension of Trading Pending 2022 Annual Report |
| 2nd May 2023 7:30 am |
RNS |
Suspension - Roquefort Therapeutics plc |
| 13th Mar 2023 7:30 am |
RNS |
Confirmation of No Exposure to Silicon Valley Bank |
| 8th Mar 2023 7:00 am |
RNS |
Creation of New Novel Family of mRNA Therapeutics |
| 6th Mar 2023 7:00 am |
RNS |
Formation of Scientific Advisory Board |
| 1st Mar 2023 7:00 am |
RNS |
Company Presentation |
| 21st Feb 2023 7:00 am |
RNS |
Investor Presentation |
| 20th Feb 2023 7:00 am |
RNS |
Randox Licence and Royalty Agreement |
| 24th Jan 2023 7:00 am |
RNS |
MDK Oncology Antibodies Demonstrate In-Vivo Safety |
| 18th Jan 2023 8:36 am |
RNS |
Holding(s) in Company |
| 16th Jan 2023 7:00 am |
RNS |
Appointment of Auditor |
| 9th Jan 2023 7:00 am |
RNS |
Operations Update |
| 5th Dec 2022 8:07 am |
RNS |
Presentation of Midkine Oligonucleotide Program |
| 1st Dec 2022 2:00 pm |
RNS |
Resignation of Auditor |
| 25th Oct 2022 7:00 am |
RNS |
Midkine Antibody Program - Festival of Biologics |
| 11th Oct 2022 7:00 am |
RNS |
ROQ Presents Study Results at the ESGCT Conference |
